ENANTA PHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Enanta Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2012 to Q3 2024.
  • Enanta Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 21.2M shares, a 0.9% increase year-over-year.
  • Enanta Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 21.2M shares, a 0.9% increase from 2023.
  • Enanta Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 21M shares, a 1.78% increase from 2022.
  • Enanta Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 20.6M shares, a 2.14% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 21.2M +188K +0.9% Jul 1, 2024 Sep 30, 2024 10-K 2024-11-27
Q2 2024 21.2M +126K +0.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 21.2M +132K +0.63% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 21.1M +272K +1.31% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-08
Q3 2023 21M +366K +1.78% Jul 1, 2023 Sep 30, 2023 10-K 2024-11-27
Q2 2023 21.1M +344K +1.66% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 21M +484K +2.36% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 20.8M +428K +2.1% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-08
Q3 2022 20.6M +432K +2.14% Jul 1, 2022 Sep 30, 2022 10-K 2024-11-27
Q2 2022 20.7M +509K +2.52% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 20.6M +380K +1.88% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 20.4M +295K +1.47% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-08
Q3 2021 20.2M +231K +1.16% Jul 1, 2021 Sep 30, 2021 10-K 2023-11-22
Q2 2021 20.2M +181K +0.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 20.2M +249K +1.25% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 20.1M +342K +1.73% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-10
Q3 2020 19.9M +356K +1.82% Jul 1, 2020 Sep 30, 2020 10-K 2022-11-23
Q2 2020 20M +347K +1.76% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 19.9M +373K +1.91% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 19.8M +325K +1.67% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 19.6M +329K +1.71% Jul 1, 2019 Sep 30, 2019 10-K 2021-11-24
Q2 2019 19.7M +370K +1.92% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 19.5M +343K +1.79% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 19.4M +296K +1.55% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q3 2018 19.3M +189K +0.99% Jul 1, 2018 Sep 30, 2018 10-K 2020-11-25
Q2 2018 19.3M +222K +1.16% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 19.2M +159K +0.84% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 19.1M +92K +0.48% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-08
Q3 2017 19.1M +137K +0.72% Jul 1, 2017 Sep 30, 2017 10-K 2019-11-27
Q2 2017 19.1M +98K +0.52% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 19M +126K +0.67% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 19M +262K +1.4% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 18.9M +256K +1.37% Jul 1, 2016 Sep 30, 2016 10-K 2018-11-29
Q2 2016 19M +286K +1.53% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 18.9M +241K +1.29% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 18.8M +173K +0.93% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 18.7M +318K +1.73% Jul 1, 2015 Sep 30, 2015 10-K 2017-12-11
Q2 2015 18.7M +168K +0.91% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 18.7M +326K +1.78% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 18.6M +654K +3.64% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 18.4M +8.57M +87.5% Jul 1, 2014 Sep 30, 2014 10-K 2016-12-09
Q2 2014 18.5M +709K +3.98% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 18.4M +16.2M +737% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 17.9M +16.8M +1450% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-06
Q3 2013 9.79M Jul 1, 2013 Sep 30, 2013 10-K 2015-12-11
Q2 2013 17.8M +16.7M +1490% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 2.19M +1.1M +101% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 1.16M Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-13
Q2 2012 1.12M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 1.09M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.